<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">37015</article-id><article-id pub-id-type="doi">10.7554/eLife.37015</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Panproteome-wide analysis of antibody responses to whole cell pneumococcal vaccination</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-110083"><name><surname>Campo</surname><given-names>Joseph J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-110084"><name><surname>Le</surname><given-names>Timothy Q</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-110085"><name><surname>Pablo</surname><given-names>Jozelyn V</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-110086"><name><surname>Hung</surname><given-names>Christopher</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-110087"><name><surname>Teng</surname><given-names>Andy A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-84774"><name><surname>Tettelin</surname><given-names>Hervé</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-110088"><name><surname>Tate</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-4092"><name><surname>Hanage</surname><given-names>William P</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" id="author-110089"><name><surname>Alderson</surname><given-names>Mark R</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-110090"><name><surname>Liang</surname><given-names>Xiaowu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf8"/></contrib><contrib contrib-type="author" id="author-110091"><name><surname>Malley</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf9"/></contrib><contrib contrib-type="author" id="author-16032"><name><surname>Lipsitch</surname><given-names>Marc</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1504-9213</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf10"/></contrib><contrib contrib-type="author" corresp="yes" id="author-54061"><name><surname>Croucher</surname><given-names>Nicholas J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6303-8768</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf11"/></contrib><aff id="aff1"><institution>Antigen Discovery Inc</institution>, <addr-line><named-content content-type="city">Irvine</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Institute for Genome Sciences, School of Medicine</institution>, <institution>University of Maryland</institution>, <addr-line><named-content content-type="city">Baltimore</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution>PATH</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Center for Communicable Disease Dynamics, Department of Epidemiology</institution>, <institution>Harvard TH Chan School of Public Health</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution>Boston Children's Hospital</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Department of Immunology and Infectious Diseases</institution>, <institution>Harvard TH Chan School of Public Health</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Department of Infectious Disease Epidemiology</institution>, <institution>Imperial College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-56267"><name><surname>Kana</surname><given-names>Bavesh D</given-names></name><role>Reviewing editor</role><aff><institution>University of the Witwatersrand</institution>, <country>South Africa</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jcampo@antigendiscovery.com</email> (JC);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>n.croucher@imperial.ac.uk</email> (NC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>28</day><month>12</month><year>2018</year></pub-date><volume>7</volume><elocation-id>e37015</elocation-id><history><date date-type="received"><day>27</day><month>03</month><year>2018</year></date><date date-type="accepted"><day>25</day><month>12</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Campo et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Campo et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-37015-v1.pdf"/><abstract><p>Pneumococcal whole cell vaccines (WCVs) could cost-effectively protect against a greater strain diversity than current capsule-based vaccines. Immunoglobulin G (IgG) responses to a WCV were characterised by applying longitudinally-sampled sera, available from 35 adult placebo-controlled phase I trial participants, to a panproteome microarray. Despite individuals maintaining distinctive antibody 'fingerprints', responses were consistent across vaccinated cohorts. Seventy-two functionally distinct proteins were associated with WCV-induced increases in IgG binding. These shared characteristics with naturally immunogenic proteins, being enriched for transporters and cell wall metabolism enzymes, likely unusually exposed on the unencapsulated WCV's surface. Vaccine-induced responses were specific to variants of the diverse PclA, PspC and ZmpB proteins, whereas PspA- and ZmpA-induced antibodies recognised a broader set of alleles. Temporal variation in IgG levels suggested a mixture of anamnestic and novel responses. These reproducible increases in IgG binding a limited, but functionally diverse, set of conserved proteins indicate WCV could provide species-wide immunity.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Other</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000865</institution-id><institution>Bill and Melinda Gates Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Campo</surname><given-names>Joseph J</given-names></name><name><surname>Le</surname><given-names>Timothy Q</given-names></name><name><surname>Pablo</surname><given-names>Jozelyn V</given-names></name><name><surname>Hung</surname><given-names>Christopher</given-names></name><name><surname>Teng</surname><given-names>Andy A</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01AI066304</award-id><principal-award-recipient><name><surname>Lipsitch</surname><given-names>Marc</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>104169/Z/14/Z</award-id><principal-award-recipient><name><surname>Croucher</surname><given-names>Nicholas J</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000288</institution-id><institution>Royal Society</institution></institution-wrap></funding-source><award-id>104169/Z/14/Z</award-id><principal-award-recipient><name><surname>Croucher</surname><given-names>Nicholas J</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100005624</institution-id><institution>PATH</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Tate</surname><given-names>Andrea</given-names></name><name><surname>Alderson</surname><given-names>Mark R</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Joseph J Campo, is an employee of Antigen Discovery, Inc.</p></fn><fn fn-type="conflict" id="conf3"><p>Timothy Q Le, is an employee of Antigen Discovery, Inc.</p></fn><fn fn-type="conflict" id="conf4"><p>Jozelyn V Pablo, is an employee of Antigen Discovery, Inc.</p></fn><fn fn-type="conflict" id="conf5"><p>Christopher Hung, is an employee of Antigen Discovery, Inc.</p></fn><fn fn-type="conflict" id="conf6"><p>Andy A Teng, is an employee of Antigen Discovery, Inc.</p></fn><fn fn-type="conflict" id="conf7"><p>William P Hanage, work on this project was supported by consulting payments from Antigen Discovery, Inc.</p></fn><fn fn-type="conflict" id="conf8"><p>Xiaowu Liang, is an employee of Antigen Discovery, Inc. and has an equity interest in Antigen Discovery, Inc.</p></fn><fn fn-type="conflict" id="conf9"><p>Richard Malley, has received honoraria or consulting fees from Merck and Affinivax, and has received research grants through his institution from PATH, the Bill and Melinda Gates Foundation, and Pfizer.</p></fn><fn fn-type="conflict" id="conf10"><p>Marc Lipsitch, Reviewing editor, <italic>eLife</italic>, work on this project was supported by consulting payments from Antigen Discovery, Inc, has received honoraria or consulting fees from Pfizer, Affinivax, and Merck, and has received research grants through his institution from Pfizer and PATH.</p></fn><fn fn-type="conflict" id="conf11"><p>Nicholas J Croucher, work on this project was supported by consulting payments from Antigen Discovery, Inc.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The VAC-002 phase 1 study (ClinicalTrials.gov identifier: NCT01537185) was reviewed and approved by the Western Institutional Review Board and conducted in compliance with the study protocol, international standards of Good Clinical Practice and the Declaration of Helsinki. Participants were healthy adults aged 18 to 40 years at the time of consent, and had no evidence of chronic health issues, and nor any history of invasive pneumococcal disease or pneumococcal vaccination.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in the ENA under accession code ERS2169631. Proteome array data analysed in this study is available as source data files for figures one and two.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Tettelin H</collab><collab>Croucher N</collab><collab>Malley R</collab></person-group><year iso-8601-date="2018">2018</year><source>Streptococcus pneumoniae RM200 Rx1E PdT ΔlytA</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ena/data/view/ERS2169631">https://www.ebi.ac.uk/ena/data/view/ERS2169631</ext-link><comment>European Nucleotide Archived, ERS2169631</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Croucher N</collab></person-group><year iso-8601-date="2015">2015</year><source>Population genomic datasets describing the post-vaccine evolutionary epidemiology of Streptococcus pneumoniae</source><ext-link ext-link-type="uri" xlink:href="https://datadryad.org//resource/doi:10.5061/dryad.t55gq">https://datadryad.org//resource/doi:10.5061/dryad.t55gq</ext-link><comment>Dryad Digital Repository, 10.5061/dryad.t55gq</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-37015-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>